<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Although myocardial interstitial <z:mp ids='MP_0003045'>fibrosis</z:mp> has been considered to play a pathogenic role in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo> (HF), the role of perivascular <z:mp ids='MP_0003045'>fibrosis</z:mp>, another form of <z:mp ids='MP_0003045'>fibrosis</z:mp>, remains to be elucidated </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We examined 64 consecutive patients with non-ischemic HF caused by <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> (HCM, n=16), <z:e sem="disease" ids="C0152105" disease_type="Disease or Syndrome" abbrv="">hypertensive heart disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HHD</z:e>, n=11), or <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> (<z:chebi fb="20" ids="15767">DCM</z:chebi>, n=37), diagnosed by both cardiac catheterization and endomyocardial biopsy (right ventricular side of the interventricular septum) in the Tohoku University Hospital between January 2001 and April 2009 </plain></SENT>
<SENT sid="2" pm="."><plain>We calculated the collagen volume fraction (CVF) and perivascular <z:mp ids='MP_0003045'>fibrosis</z:mp> ratio (PFR) in biopsy samples and also examined Thrombolysis in <z:hpo ids='HP_0001658'>Myocardial Infarction</z:hpo> (TIMI) frame count to evaluate coronary blood flow </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: There was no significant correlation between CVF and PFR (r(2)=0.0007) </plain></SENT>
<SENT sid="4" pm="."><plain>Although CVF was comparable among HCM, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HHD</z:e>, and <z:chebi fb="20" ids="15767">DCM</z:chebi> (1.11±1.04, 1.89±1.61, and 1.41±1.48, respectively), PFR was significantly higher in HCM than in <z:chebi fb="20" ids="15767">DCM</z:chebi> (1.78±1.09 vs. 1.23±0.44, p&lt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>PFR was not correlated with cardiac function parameters, such as left ventricular (LV) ejection fraction, cardiac output, LV end-diastolic pressure, LV end-diastolic volume, aortic pressure, or pulmonary artery pressure </plain></SENT>
<SENT sid="6" pm="."><plain>However, PFR was significantly correlated with coronary flow in the left anterior descending coronary artery (as evaluated by TIMI frame count) (r(2)=0.3351, p&lt;0.0001, in <z:hpo ids='HP_0000001'>all</z:hpo>-cases combined population), but not with that in the left circumflex or right coronary artery </plain></SENT>
<SENT sid="7" pm="."><plain>This correlation remained significant in a logistic regression model tested in 7 variables (body mass index, PVR, CVF, presence of <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, and <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: These results indicate that coronary perivascular <z:mp ids='MP_0003045'>fibrosis</z:mp> is associated with the impairment of coronary blood flow although not associated with interstitial <z:mp ids='MP_0003045'>fibrosis</z:mp> or cardiac function, suggesting that it can be a new therapeutic target to improve coronary microcirculation </plain></SENT>
</text></document>